SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 142 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 53.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $898,000 | +12.2% | 81,600 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $800,000 | -9.2% | 81,600 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $881,000 | +5.4% | 81,600 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $836,000 | -26.0% | 81,600 | -5.7% | 0.00% | -50.0% |
Q2 2016 | $1,130,000 | +22.6% | 86,500 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $922,000 | +38.6% | 86,500 | +19.6% | 0.00% | 0.0% |
Q4 2015 | $665,000 | +32.5% | 72,300 | 0.0% | 0.00% | +100.0% |
Q3 2015 | $502,000 | -21.7% | 72,300 | +10.7% | 0.00% | -50.0% |
Q2 2015 | $641,000 | +17.0% | 65,300 | +5.5% | 0.00% | +100.0% |
Q1 2015 | $548,000 | +1.1% | 61,900 | 0.0% | 0.00% | -50.0% |
Q4 2014 | $542,000 | +32.8% | 61,900 | +4.6% | 0.00% | 0.0% |
Q3 2014 | $408,000 | +31.2% | 59,200 | 0.0% | 0.00% | +100.0% |
Q2 2014 | $311,000 | +15.6% | 59,200 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $269,000 | +2.7% | 59,200 | +14.1% | 0.00% | 0.0% |
Q4 2013 | $262,000 | -0.4% | 51,900 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $263,000 | +2.3% | 51,900 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $257,000 | – | 51,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 284,200 | $3,126,000 | 1.80% |
Nine Chapters Capital Management LLC | 13,600 | $150,000 | 1.42% |
Stonepine Capital Management, LLC | 216,307 | $2,379,000 | 1.28% |
GLG Partners LP | 1,588,897 | $17,478,000 | 0.97% |
MENTA CAPITAL LLC | 431,996 | $4,752,000 | 0.56% |
Sapphire Star Partners LP | 24,834 | $273,000 | 0.34% |
Yakira Capital Management, Inc. | 85,500 | $941,000 | 0.28% |
TFS CAPITAL LLC | 55,104 | $606,000 | 0.24% |
BRANT POINT INVESTMENT MANAGEMENT LLC | 100,000 | $1,100,000 | 0.13% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 102,261 | $1,125,000 | 0.12% |